Late phase research has changed substantially over the past decade. During this period of innovation and development, many myths and misconceptions about late phase research have surfaced regarding study design, outsourcing, preferred provider access, and scientific value, just to name a few. Throughout this series, a panel of post-marketing experts with diverse backgrounds in late phase research will define and disprove these myths. Join PRA Health Sciences' Maria Harrison, Vice President of Late Phase Services, in an introduction to our 10-part podcast series "Dispelling Late Phase Myths and Misconceptions" as she discusses the rationale behind these myths as well as the content that will be covered in upcoming podcasts.
Advocacy Groups in Patient-Focused Drug Development
THE INSIGHT SERIES: Can you use the same outsourcing methodologies for post-marketing studies as pre-approval research? - Part 4
As the number of preferred provider relationships grow and become more sophisticated, budget grids and assumptions must align with the needs of…
PRA Insights Report 2017 ISPOR-EU Survey Results
As our industry landscape for Real World Research has changed exponentially, our Real World Solutions team performed a short questionnaire at ISPOR…